Finance AbCellera Biologics (ABCL) Advances Proprietary Pipeline with Promising Phase 1 Trial ResultsAugust 19, 20250 We just lately printed 12 Finest Healthcare Shares to Purchase Below $30. AbCellera Biologics Inc. (NASDAQ:ABCL) is among the finest…
